2'-C-Ethynylcytidine exhibits broad antitumor activity, particularly targeting indolent lymphoid malignancies; its anticancer mechanism involves inhibition of DNA synthesis and induction of apoptosis; it also serves as a click chemistry reagent, participating in copper-catalyzed azide-alkyne cycloaddition (CuAAC) reactions due to its alkyne group.